FOR HEALTHCARE PROVIDERS
A Good Choice For Your Patients.
Simple For Your Practice.
KYZATREX (testosterone undecanoate) capsules, CIII, is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone. Safety and efficacy of KYZATREX in males less than 18 years old have not been established. Safety and efficacy of KYZATREX in men with “age-related hypogonadism” (also referred to as “late-onset hypogonadism”) have not been established.
Actor Portrayal

Key Efficacy Outcomes at Day 90

In a Phase III clinical study of 139 hypogonadal men (median age 50; range 22–66), KYZATREX demonstrated the following at Day 90:1,2
of patients who completed the trial achieved normal testosterone levels at Day 901*
Increase in mean free testosterone levels from baseline at Day 901
Reduction in SHBG2
*In a 6-month clinical trial of 139 men with low testosterone, 88% of patients achieved normal testosterone levels at Day 90 (worst-case scenario analysis, excluding Investigator Site 104). Among patients who completed the study (n=127), 96% achieved normal testosterone levels at Day 90.
THE Efficacy
Up to 96%
of patients got back in range1*
Phase III study. 139 men. Oral capsules.
*In a 6-month clinical trial of 139 men with low testosterone, 88% of patients achieved normal testosterone levels at Day 90 (worst-case scenario analysis, excluding Investigator Site 104). Among patients who completed the study (n=127), 96% achieved normal testosterone levels at Day 90.
The Program
Cash-pay made simple.
Patients start faster.
Enroll in KYZATREX Direct today
Proven Efficacy
Up to 96% of patients who completed the trial achieved normal testosterone levels at Day 901*
*In a 6-month clinical trial of 139 men with low testosterone, 88% of patients achieved normal testosterone levels at Day 90 (worst-case scenario analysis, excluding Investigator Site 104). Among patients who completed the study (n=127), 96% achieved normal testosterone levels at Day 90.
Convenient Oral Delivery
Two doses, twice daily. No injections, no gels, no prior authorization. Wide-dose range with flexible titration.2
KYZATREX Direct
The streamlined prescribing program that removes friction from your practice. No prior auth setup. Patients start faster. Rep and MSL support included.
THE PROGRAM

Write the Rx. We Handle the Rest.

KYZATREX Direct is the streamlined prescribing program designed to make KYZATREX the path of least resistance for appropriate hypogonadal patients in your practice.
Simple Cash-Pay Pricing
Straightforward and transparent. Patients start faster.
Patient Tools Included
Starter kits, monitoring guides, and discussion tools, ready to hand to patients at the point of Rx.
Dedicated Support
Rep access, MSL support, and onboarding assistance for your practice.
Enroll in KYZATREX Direct

My life has changed for the better."

"I have recently taken my health into my own hands after my labs reflected low testosterone. I have been on KYZATREX for more than 4 months now and my testosterone levels are back to normal. My life has changed for the better. I really do attribute this jumpstart in health to KYZATREX."

Brian N. Age 56

Real Patient Taking KYZATREX

Actor Portrayals.

References:

  1. Bernstein JS, Dhingra OP. A phase III, single-arm, 6-month trial of a wide-dose range oral testosterone undecanoate product. Ther Adv Urol. 2024;16:17562872241241864. doi: 10.1177/17562872241241864
  2. Data on file. Raleigh, NC: Marius Pharmaceuticals, 2020.